A detailed history of Ulland Investment Advisors, LLC transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Ulland Investment Advisors, LLC holds 615 shares of EW stock, worth $40,270. This represents 0.04% of its overall portfolio holdings.

Number of Shares
615
Previous 780 21.15%
Holding current value
$40,270
Previous $75,000 24.0%
% of portfolio
0.04%
Previous 0.06%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 16, 2024

SELL
$84.3 - $94.31 $13,909 - $15,561
-165 Reduced 21.15%
615 $57,000
Q3 2022

Oct 12, 2022

SELL
$82.37 - $107.29 $12,767 - $16,629
-155 Reduced 16.58%
780 $64,000
Q1 2022

May 09, 2022

BUY
$101.96 - $128.34 $15,803 - $19,892
155 Added 19.87%
935 $110,000
Q4 2021

Feb 16, 2022

BUY
$106.37 - $130.68 $82,968 - $101,930
780 New
780 $101,000

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $40.5B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Ulland Investment Advisors, LLC Portfolio

Follow Ulland Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ulland Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ulland Investment Advisors, LLC with notifications on news.